Patent Foramen Ovale and Related Neurological Diseases
DOI:
https://doi.org/10.61788/njn.v1i25.01Keywords:
cryptogenic stroke, patent foramen ovale, transesophageal echocardiographyAbstract
The anatomical closure of the foramen ovale valve occurs until the age of 2 years. In approximately 25% of people, a patent foramen ovale (PFO) persists into adulthood. Clinically significant PFOs are related with some neurological diseases such as cryptogenic stroke and migraine. This relationship necessitates close collaboration between cardiologists and neurologists. In this paper we aim to discuss diagnostic aspects of PFO, its role in the pathogenesis of ischemic stroke and the evidence for PFO closure in cryptogenic stroke.
References
Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size // J Am Coll Cardiol., 2001; 38:613-23.
Saver JL, Carroll JD, Thaler DE, Smalling RW. et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke // N Engl J Med., 2017;377:1022-32.
Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke // N Engl J Med., 2017;377:1033-42.
Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke // New England J Med., 2017; 377:1011-21.
Kavinsky CJ, Szerlip M, Goldsweig AM, Amin Z. et al. Scai guidelines for the management of patent foramen ovale // J Soc Cardiovasc Angiogr Intervent. 2022; 1:100039.
Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine intervention with starflex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with starflex septal repair implant to resolve refractory migraine headache // Circulation, 2008;117:1397-404.
Mattle HP, Evers S, Hildick-Smith D, Becker WJ. et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial // Eur Heart J., 2016; 37:2029-36.
Tobis JM, Charles A, Silberstein SD, Sorensen S. et al. Percutaneous closure of patent foramen ovale in patients with migraine: the premium trial // J Am Coll Cardiol., 2017;70: 2766-74.
Katsanos AH, Psaltopoulou T, Sergentanis TN, Frogoudaki A. et al. Transcranial doppler vs. transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: a systematic review and diagnostic test accuracy meta-analysis // Ann Neurol., 2016;79:625-35.
B.S. Rana M.R. Thomas P.A. Calvert M.J. Monaghan D. Hildick-Smith, Echocardiographic evaluation of patent foramen ovale prior to device closure, JACC Cardiovasc // Imaging 2010;3(7):749-760.
Hart RG, Diener H-C, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct // Lancet Neurol 2014;13:429-38.
Best JG, Bell R, Haque M, et al. Atrial fibrillation and stroke: a practical guide // Pract Neurol 2019;19:208-24.
Elgendy AJ., Saver JL., Amin Zahid, et al. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale - Associated Stroke // JAMA Neurol., 2020;77(7):878-86.
Kim BJ, Kim NY, Kang DW, Kim JS, Kwon SU. Provoked right-to-left shunt in patent foramen ovale associates with ischemic stroke in posterior circulation // Stroke. 2014;45:3707-10.
He D, Li Q, Xu G, Hu Z, Li X, Guo Y, et al. Clinical and imaging characteristics of PFO-related stroke with different amounts of right-to-left shunt // Brain Behav., 2018; 8:e01122.
Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke // Neurology 2013;81:619-25.
Kent DM, Saver JL, Kasner SE, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke // JAMA, 2021;326:2277-86.
Cramer SC, Rordorf G., Maki J.H. et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study // Stroke 2004;35:46-50.
Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G. et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both // N Engl J Med., 2001, 345:1740-6.
Windecker S, Stortecky S, Meier B. Paradoxical embolism // J Am Coll Cardiol. 2014;64:403-15.
Thaler DE, Ruthazer R, Weimar C, Mas JL, Serena J, Di Angelantonio E, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other pfos // Neurology. 2014; 83:221-6.
Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D. et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the pfo-asa study. Atrial septal aneurysm // Stroke. 2002;33:706-11.
Rigatelli G, Aggio S, Cardaioli P, Braggion G, Giordan M, Dell'avvocata F, et al.. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? // Cardiovasc Intervent. 2009;2:655-62.
Furlan A.J., Reisman M., Massaro J. et al. Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale // N Engl J Med 2012; 366:991-9.
Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke // N Engl J Med. 2013;368:1092-100.
Meier B, Kalesan B, Mattle H.P, Khattab A.A. et al. PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism // N Engl J Med. 2013;368:1083-91.
Lee PH, Song J-K, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale // J Am Coll Cardiol. 2018;71(20):2335-42.
Doehner W, Mazighi M, Hofmann BM, et al. Cardiovascular care of patients with stroke and high risk of stroke: the need for interdisciplinary action: a consensus report from the European Society of Cardiology Cardiovascular Round Table // Eur J Prev Cardiol 2020;27:682-92.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
